Q4 2025 Holdings
Filed 2026-02-17 | 100 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Boston Scientific Corp(BSX) | COM | 101137107 | $47.7M | 500,529 | 4.5% |
| Insulet Corp(PODD) | COM | 45784P101 | $40.0M | 140,860 | 3.8% |
| Dexcom Inc(DXCM) | COM | 252131107 | $39.0M | 587,475 | 3.7% |
| Stryker Corporation(SYK) | COM | 863667101 | $37.1M | 105,472 | 3.5% |
| CVS Health Corp(CVS) | COM | 126650100 | $35.7M | 450,212 | 3.4% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $29.8M | 36,355 | 2.8% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $28.6M | 1,768,508 | 2.7% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $27.9M | 885,639 | 2.7% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $27.4M | 665,208 | 2.6% |
| Masimo Corp(MASI) | COM | 574795100 | $26.0M | 200,000 | 2.5% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $25.3M | 410,912 | 2.4% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $25.1M | 620,877 | 2.4% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $24.5M | 788,076 | 2.3% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $23.1M | 968,602 | 2.2% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $22.7M | 834,559 | 2.2% |
| Qiagen NV(QGEN) | COM SHS | N72482206 | $22.2M | 494,351 | 2.1% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $21.2M | 1,487,283 | 2.0% |
| Eyepoint Inc(EYPT) | COM NEW | 30233G209 | $19.9M | 1,088,033 | 1.9% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $19.0M | 47,703 | 1.8% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $16.3M | 114,712 | 1.5% |
| Waters Corp(WAT) | COM | 941848103 | $15.9M | 41,899 | 1.5% |
| Mettler Toledo International(MTD) | COM | 592688105 | $15.3M | 10,988 | 1.5% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $14.9M | 410,249 | 1.4% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $13.7M | 430,155 | 1.3% |
| Agilent Technologies Inc(A) | COM | 00846U101 | $13.6M | 100,000 | 1.3% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $13.6M | 151,049 | 1.3% |
| Danaher Corporation(DHR) | COM | 235851102 | $13.5M | 58,889 | 1.3% |
| Xeris Biopharma Holdings Inc(XERS) | COM | 98422E103 | $13.3M | 1,691,585 | 1.3% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $12.9M | 150,985 | 1.2% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $12.2M | 160,179 | 1.2% |
| Waystar Hldg Corp(WAY) | COM | 946784105 | $12.1M | 369,023 | 1.2% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $12.1M | 574,023 | 1.1% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $12.0M | 60,514 | 1.1% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $11.9M | 118,712 | 1.1% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $11.4M | 145,000 | 1.1% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $10.6M | 427,690 | 1.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $10.5M | 31,875 | 1.0% |
| Cooper COS Inc(COO) | COM | 216648501 | $10.3M | 125,335 | 1.0% |
| Artivion Inc(AORT) | COM | 228903100 | $10.0M | 218,669 | 0.9% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $9.8M | 130,069 | 0.9% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $8.7M | 209,266 | 0.8% |
| Assembly Biosciences Inc(ASMB) | COM NEW | 045396207 | $8.5M | 249,357 | 0.8% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $8.4M | 128,111 | 0.8% |
| Axogen Inc(AXGN) | COM | 05463X106 | $8.2M | 250,318 | 0.8% |
| Iqvia Hldgs Inc(IQV) | COM | 46266C105 | $7.9M | 35,230 | 0.8% |
| Si-Bone Inc(SIBN) | COM | 825704109 | $7.4M | 374,382 | 0.7% |
| Doximity Inc(DOCS) | CL A | 26622P107 | $7.2M | 162,276 | 0.7% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $7.0M | 900,057 | 0.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $6.9M | 154,184 | 0.7% |
| Optimizerx Corp(OPRX) | COM NEW | 68401U204 | $6.6M | 538,649 | 0.6% |